Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,356 recalls, newest first

Class II · Moderate risk

Nature-Throid 1 GR

CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent.

Terminated cGMP deviation PD-Rx Pharmaceuticals, Inc. NDC 43063-819-01 D-0005-2021
Class II · Moderate risk

Nature-Throid

CGMP Deviations

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-7605-09 D-1624-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-7604-09 D-1623-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-6860-09 D-1622-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-9283-01 D-1621-2020
Class II · Moderate risk

Hand Sanitizer

CGMP Deviations: Product contains acetaldehyde and acetal above the allowable limits.

Terminated cGMP deviation Charles Paint Research Inc D-0792-2021
Class II · Moderate risk

Hand Sanitizer

CGMP Deviations: Product manufactured in same facility where product was found to contain acetaldehyde and acetal above the allowable limits.

Terminated cGMP deviation Charles Paint Research Inc D-0791-2021
Class II · Moderate risk

Cephalexin for Oral Suspension

CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

Terminated cGMP deviation Teva Pharmaceuticals USA NDC 0093-4177-73 D-0013-2021
Class II · Moderate risk

Cephalexin for Oral Suspension

CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

Terminated cGMP deviation Teva Pharmaceuticals USA NDC 0093-4175-73 D-0012-2021
Class II · Moderate risk

Phentermine HCL Blue Speckled tablets

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 10702-0025-10 D-1532-2020

Recalls by year